Quarterly Results

  • Company Name :
Biocon Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532523
  • NSE Symbol:
  • BIOCON
  • P/E(TTM):
  • 291.33
  • ISIN Demat:
  • INE376G01013
  • Div & Yield%:
  • 0.12
  • EPS(TTM):
  • 1.47
  • Book Value(₹):
  • 167.06
  • Market Cap(₹Cr.):
  • 69,415.38
  • Face Value(₹):
  • 5.00
Quarters :  
Particulars March 2026 ( Cr)December 2025 ( Cr)September 2025 ( Cr)
Gross Sales 604.70 621.30 583.30
Excise Duty 0.00 0.00 0.00
Net Sales 604.70 621.30 583.30
Other Operating Income 0.00 0.00 0.00
Other Income 49.80 74.80 133.80
Total Income 654.50 696.10 717.10
Total Expenditure 544.20 744.30 530.40
PBIDT 110.30 -48.20 186.70
Interest 16.70 2.30 67.20
PBDT 93.60 -50.50 119.50
Depreciation 36.20 34.00 33.80
Tax -1.20 8.90 3.20
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 7.60 -17.00 11.60
Reported Profit After Tax 51.00 -76.40 70.90
Extra-ordinary Items -16.31 -187.40 0.00
Adjusted Profit After Extra-ordinary item 67.31 111.00 70.90
EPS (Unit Curr.) 0.32 -0.57 0.55
EPS (Adj) (Unit Curr.) 0.32 -0.57 0.55
Calculated EPS (Unit Curr.) 0.31 -0.57 0.53
Calculated EPS (Adj) (Unit Curr.) 0.31 -0.57 0.53
Calculated EPS (Ann.) (Unit Curr.) 1.26 -2.29 2.12
Calculated EPS (Adj) (Ann.) (Unit Curr.) 1.26 -2.29 2.12
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 810.50 668.50 668.50
Reserve & Surplus 0.00 0.00 0.00
Face Value 5.00 5.00 5.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 18.24 -7.76 32.01
PBDTM(%) 15.48 -8.13 20.49
PATM(%) 8.43 -12.30 12.15